Concepedia

Dennis B. Leveson-Gower

DB

13

Publications

1.6K

Citations

13

H-Index

2004

Active since

Affiliations

Stanford University(Current)

University of Freiburg

Novartis (United States)

Dennis B. Leveson-Gower is an author at Stanford University specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

2004–2020

13

Publications

13

Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells

Robert Zeiser, Dennis B. Leveson-Gower, Elizabeth A. Zambricki et al. · Blood · 2007 · 390 citations · Full text

NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects

Janelle A. Olson, Dennis B. Leveson-Gower, Saar Gill et al. · Blood · 2010 · 372 citations · Full text

Short-Term Immunosuppression Promotes Engraftment of Embryonic and Induced Pluripotent Stem Cells

Jeremy I. Pearl, Andrew S. Lee, Dennis B. Leveson-Gower et al. · Cell stem cell · 2011 · 180 citations · Full text

, , +10

Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells

Ho‐Jin Shin, Jeanette Baker, Dennis B. Leveson-Gower et al. · Blood · 2011 · 147 citations · Full text

Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4–dependent mechanism

Dennis B. Leveson-Gower, Janelle A. Olson, Emanuela Sega et al. · Blood · 2011 · 111 citations · Full text

Rows per page

1–5 of 13